The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1

Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours

(2017) Klaus-Peter Dieckmann et al.   EUROPEAN UROLOGY

Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?

(2017) A. Radtke et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Pure Testicular Seminoma with Non-Pathologic Elevation of Alpha Fetoprotein: A Case Series

(2017) Klaus-Peter Dieckmann et al.   UROLOGIA INTERNATIONALIS

Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series

(2017) Petra Anheuser et al.   UROLOGIA INTERNATIONALIS

The epigenetics of testicular germ cell tumors: looking for novel disease biomarkers

(2017) Ana Laura Costa et al.   Epigenomics

microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients

(2017) Ton van Agthoven et al.   CELLULAR ONCOLOGY

The present and future of serum diagnostic tests for testicular germ cell tumours

(2016) Matthew J. Murray et al.   Nature Reviews Urology

MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid

(2016) Klaus-Peter Dieckmann et al.   UROLOGIA INTERNATIONALIS

Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test)

(2016) Ton van Agthoven et al.   Oncotarget

A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours

(2015) Matthew J Murray et al.   BRITISH JOURNAL OF CANCER

Guidelines on Testicular Cancer: 2015 Update

(2015) Peter Albers et al.   EUROPEAN UROLOGY

Epigenetic biomarkers in the blood of patients with urological malignancies

(2015) Jörg Ellinger et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer

(2015) Isabella Syring et al.   JOURNAL OF UROLOGY

MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker

(2014) M. Spiekermann et al.   Andrology

Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle

(2013) Ad J.M. Gillis et al.   Molecular Oncology

Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors

(2012) C. Massard et al.   ANNALS OF ONCOLOGY

Serum Levels of MicroRNAs miR-371-3: A Novel Class of Serum Biomarkers for Testicular Germ Cell Tumors?

(2012) Gazanfer Belge et al.   EUROPEAN UROLOGY

A new generation of biomarkers for malignant germ cell tumours

(2012) Matthew J. Murray et al.   Nature Reviews Urology

Die humane plazentare alkalische Phosphatase (hPLAP) ist der am häufigsten erhöhte Serummarker beim Hodentumor

(2011) A. Neumann et al.   AKTUELLE UROLOGIE

Markersysteme beim Hodentumor

(2011) S. Krege et al.   UROLOGE

American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors

(2010) Timothy D. Gilligan et al.   JOURNAL OF CLINICAL ONCOLOGY

Serum tumor markers in testicular cancer

(2010) Yaron Ehrlich et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS